Powered by: Motilal Oswal
1/02/2021 4:58:04 PM | Source: Angel Broking Ltd
Pharma sector based on Budget 2021-22 By Yash Gupta, Angel Broking
News By Tags | #5948 #5238 #607 #642 #6174
Pharma sector based on Budget 2021-22 By Yash Gupta, Angel Broking

Below are View on Pharma sector based on Budget 2021-22 By Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd

Can vaccines be a game changer for the Pharma industry?

The Budget outlay for Health and Wellbeing is 2,23,846 crores in BE 2021-22 as against this year’s BE of 94,452 crores an increase of 137 percentage. The Pneumococcal Vaccine, a Made in India product, is presently limited to only 5 states and will be rolled out across the country. This will avert more than 50,000 child deaths annually. Along with this separate 35,000 crores for Covid-19 vaccine in BE 2021-22 and if required more then committed to provide further funds also.

This will be positive for Cadila Healthcare and Pfizer Ltd.

 

Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here